PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
An 8-week randomized controlled trial examining daily pecan consumption (68g) in adults at risk for cardiovascular disease found no significant differences between groups in markers of appetite (CCK, PYY, ghrelin) or subjective appetite scales [PMID:35307465].
Review of nutshell extracts suggests potential protective roles in cardiovascular disease, diabetes, neurodegeneration, and cancer via reduced lipid peroxidation and improved glucose metabolism [PMID:41900091, PMID:34986772].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36832940 (2023) — Proteomic Analysis of Pecan (Carya illinoinensis) Nut Development. · Foods (Basel, Switzerland)
- 2.PMID: 34986772 (2022) — Phytochemical Content and Potential Health Applications of Pecan [Carya illinoinensis (Wangenh) K. Koch] Nutshell. · Current topics in medicinal chemistry
- 3.PMID: 34391935 (2021) — Immunoproteomic identification of allergenic proteins in pecan (Carya illinoinensis) pollen. · Journal of proteomics
- 4.PMID: 35307465 (2022) — Appetite responses to pecan-enriched diets. · Appetite
- 5.PMID: 34849807 (2021) — Full-length transcriptome analysis of pecan (Carya illinoinensis) kernels.